Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sanero Medical is a German digital health company that specializes in developing evidence-based medical apps, known as Digital Health Applications (DiGA), which can be prescribed by physicians and psychotherapists. Founded in 2020 as NichtraucherHelden GmbH and later rebranded, the company focuses on cognitive behavioral therapy approaches to address chronic conditions and lifestyle-related disorders. Its flagship product, the NichtraucherHelden-App, is a permanently approved DiGA for smoking cessation and tobacco dependence that utilizes medical storytelling and behavioral coaching. Additionally, Sanero Medical is developing the Tony-App (Tony Blutdruckcoach), a digital coaching program designed to help patients manage and reduce high blood pressure through lifestyle modifications. In 2025, the company entered into a strategic partnership with Chiesi Germany to expand the reach and adoption of its smoking cessation application among healthcare professionals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sanero Medical.